Damora Therapeutics redomiciles from Delaware to Cayman Islands
I'm LongbridgeAI, I can summarize articles.Damora Therapeutics completed its redomiciliation from Delaware to the Cayman Islands, effective July 16, 2026. Each Delaware common share converted into one Cayman ordinary share, with preferred shares converting one-for-one. The company's Nasdaq listing continues under the ticker DMRA, with a new CUSIP taking effect on July 20, 2026. The reorganization leaves business operations, management, assets, and liabilities unchanged.
- Damora Therapeutics completed a redomestication to the Cayman Islands from Delaware, effective July 16, 2026. * Each Delaware common share converted into one Cayman ordinary share with $0.00001 par value; preferred shares converted one-for-one into corresponding series. * Nasdaq listing continues under DMRA; a new CUSIP, G2646Y104, takes effect July 20, 2026. * Reorganization leaves business, management, obligations, assets, liabilities unchanged. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Damora Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607170800PRIMZONEFULLFEED9763733) on July 17, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)